Medicinal product designation for TB-403 for medulloblastoma

Pooled analysis questions reliability of an endpoint used in multi-cancer detection trials

An analysis by researchers from the International Agency for Research on Cancer casts doubt on validity of an endpoint used in key studies of multi-cancer detection tests.

April 12, 2024

Vol.50 No.15

By Jacquelyn Cobb

NCI Director's Report

Rathmell: To improve funding outlook, we must reverse distrust in science

With NCI funding expected to remain flat through fiscal year 2025, health professionals and leaders in oncology should use this time to amp up institutional efforts to collaborate and rebuild trust in science, NCI Director Kimryn Rathmell said.

April 12, 2024

Vol.50 No.15

By Matthew Bin Han Ong

Health Equity

NCI creates Cancer Equity Leaders group to improve cancer health equity

To address inequities in cancer health, NCI is collaborating with a diverse team of experts and cancer center directors—named the Cancer Equity Leaders (CEL)—to learn from communities and inform workforce development as well as outreach initiatives.

April 12, 2024

Vol.50 No.15

By Matthew Bin Han Ong

Guest Editorial

Association of Cancer Center Administrators holds inaugural meeting in Philadelphia

Sporting a leprechaun’s hat and a giant green bowtie, Matthew Huesser, DBA, conference chairperson and vice president for cancer research administration at the Sidney Kimmel Cancer Center at Thomas Jefferson University, welcomed over 400 attendees to Philadelphia for the inaugural meeting of the Association of Cancer Center Administrators.

Edward Copeland, surgeon and breast cancer expert, dies at 86

A renowned surgeon and international authority on breast cancer, American College of Surgeons Past-President Edward (Ted) M. Copeland III, died on March 31 at the age of 86.

April 12, 2024

Vol.50 No.15

By Bulletin editorial team, American College of Surgeons